Stock Events

Biotoxtech 

₩4,500
2
+₩0+0% Today

Statistics

Day High
4,560
Day Low
4,450
52W High
7,430
52W Low
4,000
Volume
4,062
Avg. Volume
80,021
Mkt Cap
73.79B
P/E Ratio
-
Dividend Yield
-
Dividend
-

Earnings

14AugExpected
Q3 2017
Q4 2017
Q1 2018
Q2 2018
Q3 2018
Q1 2024
Q2 2024
-126.51
3.66
133.83
264
Expected EPS
N/A
Actual EPS
N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow 086040.KQ. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.
STPharmLtd
237690.KQ
Mkt Cap2.14T
Korea Drug Development Fund invests in biotech and pharmaceutical companies, directly competing with Biotoxtech in the drug development sector.
Access Bio
950130.KQ
Mkt Cap213.35B
Osstem Implant is involved in medical research and development, competing in the biotech space similar to Biotoxtech.
e-Credible
092130.KQ
Mkt Cap153.68B
Seegene Inc specializes in molecular diagnostics, a field closely related to Biotoxtech's biotechnological testing and analysis.
Seegene
096530.KQ
Mkt Cap1.11T
Sillajen Biotherapeutics focuses on biopharmaceuticals, directly competing with Biotoxtech in the biotech industry.
Komipharm International.
041960.KQ
Mkt Cap302.02B
Curevac is engaged in the development of vaccines and therapeutic proteins, competing in the biopharmaceutical sector like Biotoxtech.
Humasis.
205470.KQ
Mkt Cap174.71B
Pharmicell works on cell therapy products, which is a direct competition to Biotoxtech's offerings in biotechnological therapies.
Telcon RF Pharmaceutical
200230.KQ
Mkt Cap70.95B
CJ HealthCare is a major player in healthcare and biopharmaceuticals, competing across several of Biotoxtech's key areas.
CaregenLtd
214370.KQ
Mkt Cap824.94B
Genexine is involved in the clinical stage biotechnology, similar to Biotoxtech's focus on biotechnological research and development.
Enzychem Lifesciences
183490.KQ
Mkt Cap0
GenNBio focuses on immunotherapy products, competing in the biotech sector where Biotoxtech is also a key player.
Kolon TissueGene
950160.KQ
Mkt Cap0
JYP Entertainment, while primarily an entertainment company, has ventured into biotech, indirectly competing with Biotoxtech.

About

Biotoxtech Co., Ltd. engages in the safety evaluation of pharmaceuticals, foods, cosmetics, cell therapeutics, chemicals, agrochemicals, and medical equipment in South Korea. It is involved in the PK/TK, ADME, and RI analysis, as well as validation and bio analysis; efficacy evaluation and screening materials; clinical pathology and business contract of histopathology; new drug development; and business consulting and vicegerent of nonclinical trial activities. The company's safety evaluation research field includes general toxicity studies, carcinogenicity studies, local toxicity studies, reproductive and developmental studies, genotoxicity studies, immunotoxicity studies, safety pharmacology, ecotoxicology studies, histopathology/clinical pathology, and juvenile animal toxicity studies. Biotoxtech Co., Ltd. was founded in 2000 and is headquartered in Cheongwon, South Korea.
Show more...
CEO
Mr. Jong-Koo Kang Ph.D.
Employees
208
Country
KR
ISIN
KR7086040003

Listings